According to a WHO report, nearly 10 percent of drugs worldwide are counterfeit and in some countries, more than 50 percent of the drug-supply is made up counterfeit drugs.
The annual earnings of counterfeit drugs are more than $32 billion. The facts and figures tell the gravity of the drug counterfeiting problem prevailing in the world today.
Launching a fight against drug counterfeiting, IBM has introduced an electronic pedigree (ePedigree) system based on RFID technology that tracks drugs that pass through the supply chain before reaching to the customers.
IBM has been developing RFID tags on drug packages to check out the authenticity of a particular substance. The leading drug wholesalers such as AmerisourceBergen Corporation and Cardinal Health Inc are using IBM’s RFID technology in their supply chain managements.
The new ePedigree system developed by IBM will be enabling retailers and distributors to correspond more efficiently with manufacturers over secure networks allowing them to confirm that each package is authentic and not a counterfeit persists in the supply chain.
Comments
IBM is very gaint IT company.It can bring anything . . .